Emily L. Heil
- Pharmacology top 1%
- Epidemiology top 5%
- Molecular Medicine top 0.5%
- Applied Microbiology and Biotechnology top 0.1%
- Infectious Diseases top 2%
- Co-authors
- J. Kristie JohnsonPranita D. TammaKimberly C. ClaeysJulie Ann JustoAmy J. MathersRobert A BonomoMichael J. SatlinJacqueline Bork
- Topics
- Antibiotics Pharmacokinetics and Efficacy (46 papers)Antibiotic Use and Resistance (42 papers)Bacterial Identification and Susceptibility Testing (38 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEClinical Infectious Diseases
- Partner nations
- United StatesZambiaCanada
In The Last Decade
Emily L. Heil
129 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Pharmacology 905
- Epidemiology 836
- Molecular Medicine 748
- Applied Microbiology and Biotechnology 744
- Infectious Diseases 646
Countries citing papers authored by Emily L. Heil
This map shows the geographic impact of Emily L. Heil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily L. Heil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily L. Heil more than expected).
Fields of papers citing papers by Emily L. Heil
This network shows the impact of papers produced by Emily L. Heil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily L. Heil. The network helps show where Emily L. Heil may publish in the future.
Co-authorship network of co-authors of Emily L. Heil
This figure shows the co-authorship network connecting the top 25 collaborators of Emily L. Heil. A scholar is included among the top collaborators of Emily L. Heil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily L. Heil. Emily L. Heil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infectionsbreakdown → | 328 |
| 4 | 16 | |
| 5 | 20 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 16 | |
| 9 | 3 | |
| 10 | 17 | |
| 11 | 6 | |
| 12 | 8 | |
| 13 | 2 | |
| 14 | 16 | |
| 15 | 7 | |
| 16 | 25 | |
| 17 | 24 | |
| 18 | 4 | |
| 19 | 16 | |
| 20 | 30 |
About Emily L. Heil
Emily L. Heil is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 139 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (46 papers), Antibiotic Use and Resistance (42 papers) and Bacterial Identification and Susceptibility Testing (38 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (744 citations), Molecular Medicine (748 citations) and Clinical Biochemistry (608 citations). Emily L. Heil has collaborated with scholars based in United States, Zambia and Canada. Frequent co-authors include J. Kristie Johnson, Pranita D. Tamma, Kimberly C. Claeys, Julie Ann Justo, Amy J. Mathers, Robert A Bonomo, Michael J. Satlin, Jacqueline Bork, Jeffrey R. Strich and Henry Masur. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.